Introduction: Upadacitinib has demonstrated high and rapid rates of efficacy in adolescent and adult patients with moderate-to-severe atopic dermatitis (AD) as assessed by the Eczema Area and Severity
The study aim to compare ticagrelor monotherapy following ticagrelor dual antiplatelet therapy (DAPT) (ticagrelor + aspirin) with clopidogrel DAPT (clopidogrel + aspirin) in elderly patients with unst